Methylprednisolone treatment for vertigo typically involves a short course of high-dose intravenous (IV) medication, followed by a tapering oral regimen. The specific dosage depends on the severity of the vertigo and the patient’s overall health. Always follow your doctor’s instructions precisely.
A common IV regimen involves a bolus dose of 1000 mg on the first day, followed by daily doses of 500 mg for three to five days. After this, patients often transition to oral methylprednisolone. The oral dose is usually tapered gradually to prevent sudden withdrawal symptoms. A typical tapering schedule might decrease the daily dose by 10-20 mg every other day.
For example, after the IV course, a patient might start with 40 mg daily orally, dropping to 30 mg, then 20 mg, and finally 10 mg before discontinuation. The exact schedule depends on individual needs and response to treatment. Close monitoring by a physician is crucial during this period.
| Intravenous (IV) | 1000 mg (day 1), 500 mg daily (days 2-5) | 5 days (may vary) | High-dose initial treatment |
| Oral | Initial dose varies, gradually tapered down | Varies; typically 7-10 days | To minimize withdrawal effects |
Remember, this information is for general understanding only and does not substitute for professional medical advice. Individualized treatment plans should be determined by a physician based on your specific condition and medical history.


